St. Jude Medical, Inc. (NYSE:STJ)
Develops, manufactures and distributes cardiovascular medical devices for the cardiac rhythm management, cardiac surgery, cardiology, and atrial fibrillation therapy areas and implantable neuromodulation devices for the management of chronic pain.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
1. Make profit
2. Target market: the heart issue sufferers, profitable
3. field saturated with competitors that see the exact same thing
As with anpi, on bad device could spoil the pot.
Recs
ICD market is under penetrated.
Recs
Strong company at a value, near 52 week low.
Recs
ICD sales will return to double digit growth in 2007. SJM will be an acquisition target
Recs
ICD market to rebound
Recs
ICD market that SJM relies heavily on is stagnet.
Recs
It will be aquired
Recs
New, physician friendloy software will give it an edge
Recs
selling is overdone
Recs
The premier leader in the sector, hands down.
Recs
After the Acquisition, and everything is finally back to normal.
Recs
equity was oversold, now at an attractive entry point
Recs
continuing to take market share
Recs
This is a $60 stock trading at a 40% discount, IMO.
Recs
Only 10% off its 52-week bottom, poised to break through resistance point. A growth stock, with a bit of value now, the PEG is a respectable 1.55. With great operating margin, and return on equity, and especially, new products expected down the line, this should get into the mid 40's in next 6 months.
Recs
Baby boomer play.
Recs
Forget ICD sales in the USA. Focus on worldwide growth.
Recs
Great management, heavy R&D expenditures, good focus on customers
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 41 - 58 of 58 : « Previous 1 2 3